Aurinia Pharmaceuticals Inc (AUP.TO)
AUP.TO on Toronto Stock Exchange
8.09CAD
8:59pm GMT
8.09CAD
8:59pm GMT
Change (% chg)
$-0.21 (-2.53%)
$-0.21 (-2.53%)
Prev Close
$8.30
$8.30
Open
$8.34
$8.34
Day's High
$8.34
$8.34
Day's Low
$8.07
$8.07
Volume
27,316
27,316
Avg. Vol
65,101
65,101
52-wk High
$10.47
$10.47
52-wk Low
$6.44
$6.44
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 0.38 | -0.215 |
| Jun '18 | 0.03 | -0.186 | |
| Mar '18 | 0.03 | -0.184 | |
| FY 2017 | Dec '17 | 0.03 | -0.040 |
| Sep '17 | 0.03 | -0.157 | |
| Jun '17 | 0.33 | -0.029 | |
| Mar '17 | 0.03 | -0.916 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 1 | 0.10 | 0.10 | 0.10 | -- |
| Quarter Ending Jun-19 | 1 | 0.10 | 0.10 | 0.10 | -- |
| Year Ending Dec-19 | 2 | 0.21 | 0.30 | 0.12 | 0.12 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 1 | -0.22 | -0.22 | -0.22 | -- |
| Quarter Ending Jun-19 | 1 | -0.22 | -0.22 | -0.22 | -- |
| Year Ending Dec-19 | 2 | -0.81 | -0.72 | -0.90 | -0.51 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.44 | 33.70 | |
| P/E High - Last 5 Yrs. | -- | 147.79 | 49.87 | |
| P/E Low - Last 5 Yrs. | -- | 47.97 | 24.25 | |
| Beta | 2.13 | 1.08 | 0.90 | |
| Price to Sales (TTM) | 1,306.17 | 49.51 | 6.29 | |
| Price to Book (MRQ) | 3.08 | 10.14 | 5.26 | |
| Price to Tangible Book (MRQ) | 3.36 | 13.78 | 6.77 | |
| Price to Cash Flow (TTM) | -- | 56.20 | 24.98 | |
| % Owned Institutions | -- | 3.74 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.40 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 0.79 | 4.85 | |
| Payout Ratio(TTM) | -- | 7.02 | 41.03 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 498.18 | 206.17 | 12.76 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 86.28 | 48.79 | 5.84 | |
| Sales - 5 Yr. Growth Rate | -28.98 | 22.76 | 11.23 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 71.27 | 75.85 | 47.15 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -161.99 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 11.98 | 10.85 | |
| Capital Spending - 5 Yr. Growth Rate | -53.80 | 9.07 | 15.20 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.24 | 2.25 |
| Current Ratio (MRQ) | 53.07 | 3.50 | 3.08 |
| LT Debt to Equity (MRQ) | 0.00 | 18.65 | 11.38 |
| Total Debt to Equity (MRQ) | 0.00 | 31.33 | 16.12 |
| Interest Coverage (TTM) | -- | -43.11 | 29.47 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 99.29 | 56.24 | 53.81 | |
| Gross Margin - 5 Yr. Avg. | 98.72 | 60.48 | 52.18 | |
| EBITD Margin (TTM) | -7,859.62 | -- | -- | |
| EBITD - 5 Yr. Avg | -847.60 | -110.40 | 12.87 | |
| Operating Margin (TTM) | -8,206.41 | -184.63 | 6.19 | |
| Operating Margin - 5 Yr. Avg. | -984.31 | -126.89 | 8.31 | |
| Pre-Tax Margin (TTM) | -16,648.93 | -175.33 | 7.15 | |
| Pre-Tax Margin - 5 Yr. Avg. | -996.77 | -132.68 | 8.61 | |
| Net Profit Margin (TTM) | -16,648.93 | -182.03 | 3.29 | |
| Net Profit Margin - 5 Yr. Avg. | -946.52 | -137.07 | 4.89 | |
| Effective Tax Rate (TTM) | -- | 22.48 | 22.91 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.51 | 23.38 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 26,384 | 7,654,569 | 842,388,426 | |
| Net Income/Employee (TTM) | -4,392,666 | 562,108 | 99,841,620 | |
| Receivable Turnover (TTM) | 2.52 | 6.23 | 5.71 | |
| Inventory Turnover (TTM) | -- | 1.89 | 3.47 | |
| Asset Turnover (TTM) | 0.00 | 0.32 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -58.90 | 6.39 | 11.06 | |
| Return on Assets - 5 Yr. Avg. | -49.46 | 5.47 | 12.20 | |
| Return on Investment (TTM) | -60.83 | 8.92 | 14.45 | |
| Return on Investment - 5 Yr. Avg. | -57.68 | 6.78 | 15.87 | |
| Return on Equity (TTM) | -70.80 | 10.08 | 15.96 | |
| Return on Equity - 5 Yr. Avg. | -85.46 | 8.32 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -26.38 | -43.69 | -28.98 |
| EPS (TTM) % | -14.09 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Aurinia Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 1.10 | -3.68 | 90 | 99 |
| 13 Week | 0.73 | -3.76 | 99 | 95 |
| 26 Week | -12.39 | -12.73 | 75 | 98 |
| 52 Week | 22.88 | 14.03 | 99 | 72 |
| YTD | 192.23 | 184.04 | 99 | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 26.51% |
| # of Holders: | 79 |
| Total Shares Held: | 22,668,997 |
| 3 Mo. Net Change: | 778,015 |
| # New Positions: | 7 |
| # Closed Positions: | 11 |
| # Increased Positions: | 30 |
| # Reduced Positions: | 31 |
| # Net Buyers: | -1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.